Botulinum Toxin A Upper Limb Rehabilitation Clinical Guidance

6 November 2019

The UK and Ireland Upper Limb Rehabilitation Network has produced a consensus level guidance document to support the clinical reasoning and processes that accompany the administration of Botulinum Toxin Type A as an adjunct to evidence-based upper limb therapy in children and young people under 19 years of age. 

NICE Guidelines (published)

Clinical guidelines from the National Institute for Health and Care Excellence

Practical Symptom Management in Pandemic Flu

Capacity planning for the management of children with palliative care needs and those receiving end of life care in the event of an influenza pandemic

Quality Principles for Paediatric Disability Services

A guide for those involved in delivering, commissioning or receiving services for disabled children and young people

Supporting Treatment and Appropriate Medication in Paediatrics

Ensuring children and young people with a learning disability, autism, or both are able to access appropriate medication
British Academy of Childhood Disability is registered in England and Wales under charity number 1177868
Log in | Powered by White Fuse